Elena V Rosca

Title: Innovations of Elena V Rosca in Biomedical Research

Introduction

Elena V Rosca is a prominent inventor based in Baltimore, MD (US), known for her significant contributions to biomedical research. She holds 4 patents that focus on innovative treatments for diseases related to angiogenesis and lymphangiogenesis. Her work has the potential to impact various medical fields, particularly in cancer and ocular diseases.

Latest Patents

Among her latest patents, Elena has developed mimetic peptides derived from collagen type IV. These peptides are designed for treating angiogenesis- and lymphangiogenesis-dependent diseases. The patents disclose mimetic peptides that possess anti-angiogenic and anti-tumorigenic properties. They demonstrate anti-angiogenic activity in endothelial cell proliferation, migration, adhesion, and tube formation assays. Additionally, these peptides exhibit anti-migratory activity in human breast cancer cells in vitro and show anti-angiogenic and anti-tumorigenic activity in vivo in breast cancer xenograft models and age-related macular degeneration models. The disclosed mimetic peptides also exhibit anti-lymphangiogenic and directly anti-tumorigenic properties.

Career Highlights

Elena has worked with esteemed institutions, including The Johns Hopkins University, where she has contributed to groundbreaking research. Her expertise in the field has led to the development of innovative solutions for complex medical challenges.

Collaborations

Elena has collaborated with notable professionals such as Aleksander S Popel and Jacob E Koskimaki. These collaborations have further enhanced her research and the impact of her inventions.

Conclusion

Elena V Rosca's work exemplifies the intersection of innovation and medical research, showcasing her dedication to improving health outcomes through her patented inventions. Her contributions continue to pave the way for advancements in the treatment of critical diseases.